Tevogen Bio (TVGNW) Competitors $0.08 -0.01 (-7.87%) As of 02/21/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends TVGNW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying Tevogen Bio stock or one of its competitors? The main competitors of Tevogen Bio include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. Tevogen Bio vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Tevogen Bio (NASDAQ:TVGNW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations. Which has higher earnings and valuation, ATNFW or TVGNW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ATevogen BioN/AN/AN/AN/AN/A Does the media refer more to ATNFW or TVGNW? In the previous week, 180 Life Sciences had 1 more articles in the media than Tevogen Bio. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Tevogen Bio. 180 Life Sciences' average media sentiment score of 1.38 beat Tevogen Bio's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive Tevogen Bio Neutral Does the MarketBeat Community believe in ATNFW or TVGNW? 180 Life Sciences and Tevogen Bio both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ATevogen BioN/AN/A Is ATNFW or TVGNW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Tevogen Bio N/A N/A N/A Summary180 Life Sciences beats Tevogen Bio on 2 of the 2 factors compared between the two stocks. Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGNW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TVGNW vs. The Competition Export to ExcelMetricTevogen BioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$117.96M$5.84B$9.14BDividend YieldN/A3.69%4.76%3.85%P/E RatioN/A3.2018.2614.95Price / SalesN/A4,826.69434.4770.76Price / CashN/A13.0138.4235.17Price / BookN/A47.077.644.65Net IncomeN/A-$87.82M$3.18B$245.69M7 Day PerformanceN/A0.35%-1.95%-2.68%1 Month PerformanceN/A3.62%-0.23%-2.16%1 Year PerformanceN/A99.12%16.69%12.90% Tevogen Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TVGNWTevogen BioN/A$0.08-7.9%N/AN/A$0.00N/A0.0017Gap DownHigh Trading VolumeATNFW180 Life SciencesN/A$0.01-6.1%N/A+51.5%$0.00N/A0.007News CoverageGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.03-18.2%N/A-70.0%$0.00$502,409.000.002News CoverageGap DownHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.32-8.6%N/A+12.0%$0.00N/A0.0080Gap UpWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01+9.1%N/A-59.7%$0.00N/A0.0059Positive NewsGap UpBCTXWBriaCell TherapeuticsN/A$0.13+11.2%N/A-92.9%$0.00N/A0.008Gap DownHigh Trading VolumeCDIOWCardio DiagnosticsN/A$0.08+9.3%N/A-24.4%$0.00$35,688.000.007Gap UpCTCXWCarmellN/A$0.04+59.4%N/A-80.6%$0.00$32,839.000.0014Gap UpCELUWCelularityN/A$0.07+14.4%N/A+120.8%$0.00$48.20M0.00220Gap UpCEROWCERo TherapeuticsN/A$0.01-30.2%N/AN/A$0.00N/A0.008Positive NewsGap Down Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors WENAW Competitors APLMW Competitors BCTXW Competitors CDIOW Competitors CTCXW Competitors CELUW Competitors CEROW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TVGNW) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.